ÂÜÀòÂÒÂ×

Robert Meehan is a seasoned professional in clinical development with extensive experience in the pharmaceutical and medical research sectors. Currently serving as Vice President of Clinical Development at Dragonfly Therapeutics, Inc. since June 2024, Robert previously held multiple roles at Moderna from April 2017 to June 2024, including Senior Director and Director of Clinical Development. Prior to Moderna, Robert contributed to the National Cancer Institute as an Early Therapeutics Clinic Staff Clinician from June 2015 to May 2017, and completed a Hematology/Oncology Fellowship at Boston University School of Medicine from July 2012 to June 2015. Robert's early career included leadership positions such as Chief Resident at Roger Williams Medical Center, where Robert practiced from June 2008 to June 2012. Robert earned a Doctor of Medicine degree from Poznan University of Medical Sciences between 2004 and 2008 and has educational credentials from Boston University and Boston University Academy.